| 000 | 01324 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512203133.0 | ||
| 264 | 0 | _c19840522 | |
| 008 | 198405s 0 0 eng d | ||
| 022 | _a0142-2782 | ||
| 024 | 7 |
_a10.1002/bdd.2510050109 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKraml, M | |
| 245 | 0 | 0 |
_aBioavailability studies with etodolac in dogs and man. _h[electronic resource] |
| 260 |
_bBiopharmaceutics & drug disposition _c |
||
| 300 |
_a63-74 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAcetates _xadministration & dosage |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xmetabolism |
| 650 | 0 | 4 |
_aAnti-Ulcer Agents _xpharmacology |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEtodolac |
| 650 | 0 | 4 | _aFood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aParticle Size |
| 700 | 1 | _aCosyns, L | |
| 700 | 1 | _aHicks, D R | |
| 700 | 1 | _aSimon, J | |
| 700 | 1 | _aMullane, J F | |
| 700 | 1 | _aDvornik, D | |
| 773 | 0 |
_tBiopharmaceutics & drug disposition _gvol. 5 _gno. 1 _gp. 63-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/bdd.2510050109 _zAvailable from publisher's website |
| 999 |
_c6231050 _d6231050 |
||